S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
SHOCKING Crypto Leak Reveal Crypto's Set To SURGE (Ad)
How major US stock indexes fared Friday, 2/23/2024
MarketBeat Week in Review – 2/19 - 2/23
SHOCKING Crypto Leak Reveal Crypto's Set To SURGE (Ad)
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
Mike Tyson’s Wisdom: Life, Planning, and Resilience
66,000% upside on tiny biotech? (Ad)
White House, tribal leaders hail 'historic' deal to restore salmon runs in Pacific Northwest
MILAN FASHION PHOTOS: Gucci sparkles as De Sarno hits stride
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
SHOCKING Crypto Leak Reveal Crypto's Set To SURGE (Ad)
How major US stock indexes fared Friday, 2/23/2024
MarketBeat Week in Review – 2/19 - 2/23
SHOCKING Crypto Leak Reveal Crypto's Set To SURGE (Ad)
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
Mike Tyson’s Wisdom: Life, Planning, and Resilience
66,000% upside on tiny biotech? (Ad)
White House, tribal leaders hail 'historic' deal to restore salmon runs in Pacific Northwest
MILAN FASHION PHOTOS: Gucci sparkles as De Sarno hits stride
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
SHOCKING Crypto Leak Reveal Crypto's Set To SURGE (Ad)
How major US stock indexes fared Friday, 2/23/2024
MarketBeat Week in Review – 2/19 - 2/23
SHOCKING Crypto Leak Reveal Crypto's Set To SURGE (Ad)
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
Mike Tyson’s Wisdom: Life, Planning, and Resilience
66,000% upside on tiny biotech? (Ad)
White House, tribal leaders hail 'historic' deal to restore salmon runs in Pacific Northwest
MILAN FASHION PHOTOS: Gucci sparkles as De Sarno hits stride
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
SHOCKING Crypto Leak Reveal Crypto's Set To SURGE (Ad)
How major US stock indexes fared Friday, 2/23/2024
MarketBeat Week in Review – 2/19 - 2/23
SHOCKING Crypto Leak Reveal Crypto's Set To SURGE (Ad)
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
Mike Tyson’s Wisdom: Life, Planning, and Resilience
66,000% upside on tiny biotech? (Ad)
White House, tribal leaders hail 'historic' deal to restore salmon runs in Pacific Northwest
MILAN FASHION PHOTOS: Gucci sparkles as De Sarno hits stride

Aprea Therapeutics (APRE) Earnings Date, Estimates & Call Transcripts

$7.24
+0.87 (+13.66%)
(As of 02/23/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

APRE Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

APRE Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Aprea Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.42)($0.42)($0.42)
Q2 20241($0.45)($0.45)($0.45)
Q3 20241($0.48)($0.48)($0.48)
Q4 20241($0.51)($0.51)($0.51)
FY 20244($1.86)($1.86)($1.86)

APRE Earnings Date and Information

Aprea Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, April 4th, 2024 based off prior year's report dates.

Aprea Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
4/4/2024
Estimated)
------- 
11/9/2023Q3 2023($1.08)($0.86)+$0.22($0.86)$0.25 million$0.32 million
8/10/2023Q2 2023($1.43)($0.87)+$0.56($0.87)-$0.25 million
5/15/2023Q1 2023($1.51)($1.34)+$0.17($1.34)--
3/30/2023Q4 2022($2.60)($0.92)+$1.68($0.92)--
11/9/2022Q3 2022($5.60)($2.40)+$3.20($0.12)--
8/11/2022Q2 2022($7.60)($19.80)($12.20)$2.36--
5/16/2022Q1 2022($7.60)($7.20)+$0.40($0.36)--
3/15/2022Q4 2021($8.80)($7.20)+$1.60($0.36)--
11/8/2021Q3 2021($9.00)($9.00)-($0.45)--
8/12/2021Q2 2021($9.40)($9.60)($0.20)($0.48)--
5/6/2021Q1 2021($9.80)($9.20)+$0.60($0.46)--  
3/15/2021Q4 2020($13.60)($14.60)($1.00)($0.73)--












Aprea Therapeutics Earnings - Frequently Asked Questions

When is Aprea Therapeutics's earnings date?

Aprea Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, April 4th, 2024 based off last year's report dates. Learn more on APRE's earnings history.

How much profit does Aprea Therapeutics generate each year?

Aprea Therapeutics (NASDAQ:APRE) has a recorded net income of -$112.66 million. APRE has generated -$3.99 earnings per share over the last four quarters.

What is Aprea Therapeutics's EPS forecast for next year?

Aprea Therapeutics's earnings are expected to grow from ($3.07) per share to ($1.06) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:APRE) was last updated on 2/24/2024 by MarketBeat.com Staff